Literature DB >> 29873905

Impact of red versus blue light on tolerability and efficacy of PDT: a randomized controlled trial.

Patrick Gholam1, Ina Bosselmann1, Alexander Enk1, Christine Fink1.   

Abstract

Various light sources may be used for photodynamic therapy of actinic keratosis since photosensitizing agents are activated by different wavelengths. However, the relative impact of red and blue light irradiation on the efficacy and tolerability of therapy is controversial.
OBJECTIVE: The aim of this study is to compare the efficacy and tolerability of therapy with red versus blue light sources, as well as the patients' evaluation of cosmetic results, clinical response, painfulness and preferred light source for future photodynamic treatments.
METHODS: This is a prospective, single-center, randomized, controlled, open-label study with 28 patients undergoing elective photodynamic therapy.
RESULTS: Red and blue light sources both showed very good results with a complete response rate of 84 % and 85 % respectively. Pain during photodynamic therapy was 6.1 vs. 5.4 (and 2.1 vs. 1.5 eight hours after therapy) on the visual analogue scale. Although these differences were statistically significant, the clinical relevance is low, since the number of therapy interruptions were equally distributed in both groups, and patients' subjective evaluation of the treatment showed no personal preference towards the light sources.
CONCLUSION: Both light sources showed very good clinical results and satisfactory tolerability in this study.
© 2018 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29873905     DOI: 10.1111/ddg.13545

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  4 in total

Review 1.  Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

Authors:  Nathalie C Zeitouni; Neal Bhatia; Roger I Ceilley; Joel L Cohen; James Q Del Rosso; Angela Y Moore; Gilly Munavalli; David M Pariser; Todd Schlesinger; Daniel M Siegel; Andrea Willey; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2021-10

2.  Ablative Fractional Laser-assisted Low-irradiance Photodynamic Therapy for Treatment of Actinic Keratoses in Organ Transplant Recipients: A Prospective, Randomized, Intraindividual Controlled Trial.

Authors:  Anke S Lonsdorf; Aric Keller; Julia Hartmann; Alexander H Enk; Patrick Gholam
Journal:  Acta Derm Venereol       Date:  2022-04-13       Impact factor: 3.875

3.  The Self-Assembly of a Cyclometalated Palladium Photosensitizer into Protein-Stabilized Nanorods Triggers Drug Uptake In Vitro and In Vivo.

Authors:  Xue-Quan Zhou; Ming Xiao; Vadde Ramu; Jonathan Hilgendorf; Xuezhao Li; Panagiota Papadopoulou; Maxime A Siegler; Alexander Kros; Wen Sun; Sylvestre Bonnet
Journal:  J Am Chem Soc       Date:  2020-05-27       Impact factor: 15.419

4.  Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles.

Authors:  Luis Exequiel Ibarra; Simona Camorani; Lisa Agnello; Emilia Pedone; Luciano Pirone; Carlos Alberto Chesta; Rodrigo Emiliano Palacios; Monica Fedele; Laura Cerchia
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.